To include your compound in the COVID-19 Resource Center, submit it here.

Astellas' mAb against PSCA meets pancreatic cancer goal

Astellas Pharma Inc. (Tokyo:4503) said AGS-1C4D4 plus

Read the full 71 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE